If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
85.00    0.00 (0.00%)
Bid:
80.00
Ask:
90.00
Spread: 10.00 (12.50%)
Market Cap: £15.92m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Director/PDMR Shareholding

5 Oct 2023 07:00

RNS Number : 7399O
Maintel Holdings PLC
05 October 2023
 

Maintel Holdings Plc ("Maintel" or the "Company")

Director/PDMR Shareholding

 

The Company was notified on 4 October 2023 that, the husband of Carol Thompson, Executive Chair, purchased 127 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 165 pence per Ordinary Share.

Following this transaction, Carol Thompson husband's interest In the Company is 344 Ordinary Shares, representing approximately 0.002% of the Company's total voting rights.

 

For further information please contact:

Maintel Holdings Plc

Carol Thompson, Executive Chair

Gab Pirona, Chief Financial Officer

Dan Davies, Chief Technology Officer

0344 871 1122

Cavendish Capital Markets (Nomad and Broker)

Jonny Franklin-Adams / Emily Watts / Fergus Sullivan (Corporate Finance)

Sunila de Silva (Corporate Broking)

020 7220 0500

 

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Timothy Walter Spiers

2.

Reason for the notification

a)

Position/status:

PCA of Carol Thompson, Executive Chair

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Maintel Holdings Plc

b)

LEI:

2138008TDMNV6ODDI497

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of 1p each

 

GB00B046YG73

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 

No. of shares

Price

127

165p

d)

Aggregated information:

 

·      Aggregated volume:

 

·      Price:

See above

e)

Date of the transaction:

4 October 2023

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBIBDGSUGDGXS
Date   Source Headline
3rd Aug 200910:35 amRNSDirector/PDMR Shareholding
21st Jul 200912:00 pmRNSChange of Adviser
30th Jun 20095:22 pmRNSDirector/PDMR Shareholding/TVR
29th May 20094:23 pmRNSDirectors' shareholding/Total voting rights
19th May 20097:00 amRNSDirector/PDMR Shareholding
15th May 20093:37 pmRNSDirector/PDMR Shareholding
5th May 200911:17 amRNSHolding(s) in Company
1st May 20095:11 pmRNSDirector/PDMR Shareholding
15th Apr 20091:28 pmRNSMajor contract
1st Apr 20093:14 pmRNSDirector/PDMR Shareholding/Total Voting Rights
31st Mar 20097:00 amRNSTotal Voting Rights
30th Mar 200911:26 amRNSPosting of Annual Report and Accounts
17th Mar 200912:01 pmRNSTransaction in Own Shares
16th Mar 20097:00 amRNSFinal Results
5th Mar 200911:08 amRNSDisclosure of Material Interest in Shares
2nd Mar 200910:19 amRNSDirector/PDMR Shareholding/Total voting rights
2nd Feb 20092:37 pmRNSDirectors' shareholding/Total voting rights
15th Jan 200911:15 amRNSAppointment of CEO
5th Jan 20092:44 pmRNSDirectors shareholding/Total voting rights
23rd Dec 200810:02 amRNSTrading Statement
28th Nov 20082:48 pmRNSDirectors shareholdings/Total Voting Rights
11th Nov 20083:50 pmRNSTransaction in Own Shares
5th Nov 20084:59 pmRNSDirector/PDMR Shareholding
31st Oct 20083:20 pmRNSTotal Voting Rights
20th Oct 20083:42 pmRNSDirector Shareholding/Total voting rights
13th Oct 20083:47 pmRNSDirector shareholding/Total voting rights
6th Oct 20084:20 pmRNSHolding(s) in Company
3rd Oct 20083:06 pmRNSAcquisition of own shares/Directors' shareholding
30th Sep 200812:48 pmRNSDirectors' Shareholding /Total Voting Rights
12th Sep 20087:00 amRNSInterim Results
1st Sep 20089:51 amRNSDirector/PDMR Shareholding
31st Jul 20083:36 pmRNSDirectors holdings / TVR
10th Jul 200811:26 amRNSTransaction in Own Shares
30th Jun 20081:16 pmRNSDirector/PDMR Shareholding
3rd Jun 200812:27 pmRNSDirector/PDMR Shareholding
1st May 200811:25 amRNSDirector/PDMR Shareholding
1st Apr 20082:43 pmRNSAnnual Report and Accounts
1st Apr 200811:26 amRNSDirector/PDMR Shareholding
17th Mar 20087:00 amRNSFinal Results
11th Mar 20082:45 pmRNSHolding(s) in Company
29th Feb 20083:52 pmRNSDirector/PDMR Shareholding
1st Feb 20081:50 pmRNSDirector/PDMR Shareholding
31st Jan 200811:46 amRNSTotal Voting Rights
17th Jan 20089:21 amRNSTransaction in Own Shares
3rd Jan 20083:42 pmRNSDirector/PDMR Shareholding
31st Dec 20077:00 amRNSTotal Voting Rights
10th Dec 200710:16 amRNSTransaction in Own Shares
3rd Dec 20072:16 pmRNSDirector/PDMR Shareholding
1st Nov 20079:07 amRNSDirector/PDMR Shareholding
1st Oct 20072:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.